MARC details
| 000 -LEADER |
|---|
| fixed length control field |
07919namaa22004451i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - أخر تعامل مع التسجيلة |
|---|
| control field |
20250828114718.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
250801s2024 ua a|||frm||| 000 0 eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloguing agency |
EG-GICUC |
| Language of cataloging |
eng |
| Transcribing agency |
EG-GICUC |
| Modifying agency |
EG-GICUC |
| Description conventions |
rda |
| 041 0# - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| Language code of summary or abstract |
eng |
| -- |
ara |
| 049 ## - Acquisition Source |
|---|
| Acquisition Source |
Deposit |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
618.1 |
| 092 ## - LOCALLY ASSIGNED DEWEY CALL NUMBER (OCLC) |
|---|
| Classification number |
618.1 |
| Edition number |
21 |
| 097 ## - Degree |
|---|
| Degree |
M.Sc |
| 099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
|---|
| Local Call Number |
Cai01.11.15.M.Sc.2024.Ka.E. |
| 100 0# - MAIN ENTRY--PERSONAL NAME |
|---|
| Authority record control number or standard number |
Kareem Ashraf MohyiEldeen Mohamed Fawzy, |
| Preparation |
preparation. |
| 245 14 - TITLE STATEMENT |
|---|
| Title |
The effect of Paracetamol versus Meperidine For the Relief of Labor Pain in Primiparous Women / |
| Statement of responsibility, etc. |
By Kareem Ashraf MohyiEldeen Mohamed Fawzy; Supervised By Prof. Dr. Gamal Gamal Eldeen Youssef, Ass. Prof. Dr. Mohamed Ahmed Bahaa ElDeen, Dr. Ibrahim Fawzy Ibrahim. |
| 246 15 - VARYING FORM OF TITLE |
|---|
| Title proper/short title |
تأثير الباراسيتامول مقابل الميبيريدين في تخفيف آلام الولادة لدى النساء اللائي ينجبن للمرة الأولى |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Date of production, publication, distribution, manufacture, or copyright notice |
2024. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
98 pages : (23) pages |
| Other physical details |
illustrations ; |
| Dimensions |
25 cm. + |
| Accompanying material |
CD. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Source |
rda content |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
Unmediated |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Source |
rdacarrier |
| 502 ## - DISSERTATION NOTE |
|---|
| Dissertation note |
Thesis (M.Sc.) -Cairo University, 2024. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Bibliography: pages 88-98. |
| 520 3# - SUMMARY, ETC. |
|---|
| Summary, etc. |
Purpose: Labor pain is a significant challenge in obstetric care, influencing the physical and psychological well-being of women during childbirth. Effective management of labor pain is crucial for ensuring a positive childbirth experience and promoting maternal and neonatal health. This thesis investigates the comparative efficacy and safety of two analgesics, paracetamol and meperidine, in relieving labor pain among primiparous women.<br/>Methods: The study was conducted as a randomized controlled trial at Al Kasr Al Aini University Hospital, including 112 primiparous women with term singleton pregnancies. Participants were randomly assigned to receive either intravenous paracetamol or intramuscular meperidine during the active phase of labor.<br/>The primary outcomes measured were pain intensity, duration of labor stages, and neonatal respiratory outcomes. Secondary outcomes included the need for further analgesia, maternal side effects, and neonatal Apgar scores.<br/>Results: Results demonstrated that both paracetamol and meperidine effectively reduced labor pain. The mean VAS score for the paracetamol group was 5.59 ± 1.49, while the meperidine group had a mean VAS score of 5.34 ± 1.48, with no statistically significant difference between the groups (p = 0.37). The duration of the active stage of labor was similar between the two groups, with Group I averaging 5.76 ± 1.52 hours and Group II averaging 5.71 ± 1.54 hours (p = 0.88). The second stage of labor showed no significant difference, with a mean duration of 1.69 ± 0.39 hours in Group I and 1.70 ± 0.46 hours in Group II (p = 0.93).<br/>Notably, the incidence of maternal side effects was significantly lower in the paracetamol group. Dizziness occurred in 17.86% of women in Group I compared to 66.07% in Group II (p = 0.0001). Nausea was reported by 26.79% of women in the paracetamol group, compared to <br/>62.5% in the meperidine group (p = 0.0001), and vomiting was reported by 17.86% of women in Group I versus 53.57% in Group II (p = 0.0008).<br/><br/>Neonatal outcomes were also more favorable in the paracetamol group. The 1-minute Apgar score averaged 7.75 ± 1.01 in Group I, significantly higher than the 6.16 ± 0.95 in Group II (p = 0.0001). The 5-minute Apgar score was 8.18 ± 0.74 in the paracetamol group, compared to 7.16 ± 0.68 in the meperidine group (p = 0.0001). Additionally, the need for neonatal resuscitation was lower in the paracetamol group (12.5% vs. 25%, p = 0.06), though this difference was not statistically significant.<br/>Conclusion: This study suggests that paracetamol is a viable and safer alternative to meperidine for labor pain management in primiparous women. Its use is associated with fewer adverse maternal and neonatal outcomes, making it a preferable choice in clinical settings where minimizing side effects and optimizing maternal and neonatal health are priorities. These findings contribute to evidence-based practices in obstetric pain management, highlighting the need for further research to refine pain management protocols in labor and delivery.<br/><br/><br/> |
| 520 3# - SUMMARY, ETC. |
|---|
| Summary, etc. |
تستكشف هذه الأطروحة الفعالية والسلامة المقارنة بين الباراسيتامول والمبيريدين لإدارة ألم الولادة لدى النساء البكريات. يوضح البحث أن كلا الدواءين فعالين في تقليل ألم الولادة، لكن الباراسيتامول يتمتع بملف سلامة أفضل بكثير. ينتج عن استخدام الباراسيتامول عدد أقل من الآثار الجانبية للأم، مثل الدوار والغثيان والقيء، ويرتبط بنتائج أفضل للمولود، كما يتضح من ارتفاع درجات أبجار. ومع ذلك، احتاجت نسبة أكبر من النساء في مجموعة الباراسيتامول إلى مسكنات إضافية مقارنة بمجموعة المبيريدين، مما يبرز أن الباراسيتامول قد لا يوفر راحة كافية خلال المراحل الأكثر شدة من الولادة دون مسكنات إضافية.<br/>تشدد الدراسة على أهمية النظر في بدائل غير أفيونية مثل الباراسيتامول في البيئات التي تكون فيها استخدامات الأفيونات محدودة أو حيث يكون تقليل الآثار الجانبية أولوية. يوصى بالتوسع في استخدام الباراسيتامول سواء بمفرده أو كجزء من استراتيجية تسكين ألم متعددة الوسائط <br/>لتحسين نتائج الأم والجنين أثناء الولادة.<br/><br/>التوصيات:<br/>1. مسكن أولي: يجب اعتبار الباراسيتامول كمسكن أولي لإدارة ألم الولادة، خاصة في البيئات التي تعطي الأولوية للسلامة وتقليل الآثار الجانبية.<br/>2. تسكين ألم متعدد الوسائط: يمكن دمج الباراسيتامول في استراتيجية تسكين ألم متعددة الوسائط لمعالجة محدودياته في إدارة الألم الشديد، وربما بالاشتراك مع طرق غير دوائية أو مسكنات غير أفيونية أخرى.<br/>3. البحث المستقبلي: هناك حاجة إلى المزيد من الدراسات لاستكشاف الآثار طويلة الأمد لاستخدام الباراسيتامول أثناء الولادة ولتقييم فعاليته في مجموعات سكانية متنوعة، لا سيما عبر السياقات الثقافية المختلفة ومستويات تحمل الألم.<br/><br/><br/><br/> |
| 530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE |
|---|
| Issues CD |
Issued also as CD |
| 546 ## - LANGUAGE NOTE |
|---|
| Text Language |
Text in English and abstract in Arabic & English. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Obstetrics and Gynecology |
| 653 #1 - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
The effect of Paracetamol versus Meperidine |
| -- |
Relief of Labor Pain in Primiparous Women |
| 653 #1 - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
تأثير الباراسيتامول مقابل الميبيريدين |
| -- |
تخفيف آلام الولادة لدى النساء اللائي ينجبن للمرة الأولى |
| 700 0# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Gamal Gamal Eldeen Youssef |
| Relator term |
thesis advisor. |
| 700 0# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Mohamed Ahmed Bahaa ElDeen |
| Relator term |
thesis advisor. |
| 700 0# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Ibrahim Fawzy Ibrahim |
| Relator term |
thesis advisor. |
| 900 ## - Thesis Information |
|---|
| Grant date |
01-01-2024 |
| Supervisory body |
Gamal Gamal Eldeen Youssef |
| -- |
Mohamed Ahmed Bahaa ElDeen |
| -- |
Ibrahim Fawzy Ibrahim |
| Universities |
Cairo University |
| Faculties |
Faculty of Medicine |
| Department |
Department of Obstetrics and Gynecology |
| 905 ## - Cataloger and Reviser Names |
|---|
| Cataloger Name |
Eman El gebaly |
| Reviser Names |
Eman Ghareb |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Thesis |
| Edition |
21 |
| Suppress in OPAC |
No |